Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 3 (1)

Trial Status

Completed3
Not Yet Recruiting2
Terminated1
Unknown1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (7)

Research Network

Activity Timeline